Supriya Lifescience Ltd

Supriya Lifescience Ltd

Supriya Lifescience Ltd issued an email communication to its shareholders detailing the tax deduction at source (TDS) provisions applicable to the final dividend of Re. 1.00/- per equity share for FY2025-26, which was recommended by the board. The communication explains that dividends are taxable in the hands of shareholders and the company will deduct TDS based on residential status and submitted documents. It outlines applicable TDS rates for resident shareholders, including potential exemptions for individuals providing Form 15G/15H if the total dividend is under Rs. 10,000, and emphasizes the need for a valid and operative PAN linked with Aadhaar to ensure appropriate tax deduction.